INVO Bioscience (INVO) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChartTranscripts

INVO Bioscience Revenue Highlights


Latest Revenue (Y)

$3.02M

Latest Revenue (Q)

$1.58M

Main Segment (Y)

Clinic Revenue

INVO Bioscience Revenue by Period


INVO Bioscience Revenue by Year

DateRevenueChange
2023-12-31$3.02M267.38%
2022-12-31$822.20K-80.24%
2021-12-31$4.16M301.06%
2020-12-31$1.04M-29.92%
2019-12-31$1.48M199.41%
2018-12-31$494.38K75.22%
2017-12-31$282.14K454.30%
2016-12-31$50.90K335.46%
2015-12-31$11.69K-29.53%
2014-12-31$16.59K-38.71%
2013-12-31$27.06K-52.00%
2012-12-31$56.38K-21.15%
2011-12-31$71.50K5.70%
2010-12-31$67.65K7.03%
2009-12-31$63.20K66.35%
2008-12-31$37.99K100.00%
2007-12-31-100.00%
2006-12-31--

INVO Bioscience generated $3.02M in revenue during NA 2023, up 267.38% compared to the previous quarter, and up 610.99% compared to the same period a year ago.

INVO Bioscience Revenue by Quarter

DateRevenueChange
2024-03-31$1.58M14.08%
2023-12-31$1.38M41.73%
2023-09-30$974.89K208.61%
2023-06-30$315.90K-9.23%
2023-03-31$348.02K25.12%
2022-12-31$278.14K18.20%
2022-09-30$235.32K61.03%
2022-06-30$146.13K-10.12%
2022-03-31$162.60K-94.67%
2021-12-31$3.05M1292.69%
2021-09-30$218.87K4.99%
2021-06-30$208.47K-69.54%
2021-03-31$684.52K248.23%
2020-12-31$196.57K-41.51%
2020-09-30$336.07K36.57%
2020-06-30$246.07K-4.83%
2020-03-31$258.57K-21.30%
2019-12-31$328.57K8.24%
2019-09-30$303.57K-53.91%
2019-06-30$658.64K247.69%
2019-03-31$189.43K22.22%
2018-12-31$154.99K23.96%
2018-09-30$125.03K13.45%
2018-06-30$110.21K5.83%
2018-03-31$104.14K28.01%
2017-12-31$81.36K19.25%
2017-09-30$68.22K-15.08%
2017-06-30$80.33K53.77%
2017-03-31$52.24K448.91%
2016-12-31$9.52K-46.63%
2016-09-30$17.83K227.41%
2016-06-30$5.45K-69.92%
2016-03-31$18.11K100.00%
2015-12-31--100.00%
2015-09-30$2.51K-54.73%
2015-06-30$5.55K53.13%
2015-03-31$3.63K-3.97%
2011-12-31$3.77K-70.69%
2011-09-30$12.88K-40.90%
2011-06-30$21.79K-34.08%
2011-03-31$33.06K11.47%
2010-12-31$29.66K100.00%
2010-09-30--100.00%
2010-06-30$11.17K-58.34%
2010-03-31$26.82K288.36%
2009-12-31$6.91K142.15%
2009-09-30$2.85K-82.85%
2009-06-30$16.63K-54.83%
2009-03-31$36.81K100.00%
2008-12-31-100.00%
2008-09-30-100.00%
2008-06-30-100.00%
2008-03-31-100.00%
2007-12-31-100.00%
2007-09-30-100.00%
2007-06-30-100.00%
2007-03-31--

INVO Bioscience generated $1.58M in revenue during Q1 2024, up 14.08% compared to the previous quarter, and up 566.72% compared to the same period a year ago.

INVO Bioscience Revenue Breakdown


INVO Bioscience Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 22Dec 21Dec 20Dec 19
Clinic Revenue$614.85K$43.74K--
Product Revenue-$544.94K--
License Revenue-$3.57M--
DomesticLicensingDistributionFeeMember--$714.29K-
DomesticPhysiciansMember--$323.00K-
Domestic Physicians---$765.93K
Domestic Licensing Distribution Fee---$714.29K

INVO Bioscience's latest annual revenue breakdown by segment (product or service), as of Dec 22: Clinic Revenue (100.00%).

Quarterly Revenue by Product

Product/ServiceJun 24Mar 24Sep 23Jun 23Mar 23Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Sep 19Jun 19Mar 19
Product$28.68K$39.09K-----------------
Clinic Revenue--$947.89K$254.36K$297.38K$176.40K$112.36K$105.85K$6.23K$37.51K---------
Product Revenue------$33.78K$56.75K$6.30K$2.79K$29.90K--------
License Revenue--------$3.04M$178.57K$178.57K$178.57K-------
DomesticLicensingDistributionFeeMember------------$178.57K$178.57K$178.57K----
DomesticPhysiciansMember------------$18.00K$157.50K$67.50K----
Domestic Physicians---------------$80.00K$125.00K$480.07K$10.86K
Domestic Licensing Distribution Fee---------------$178.57K$178.57K$178.57K$178.57K

INVO Bioscience's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Product (100.00%).

INVO Bioscience Revenue Breakdown by Country

Quarterly Revenue by Country

CountryMar 23Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Sep 19Jun 19Mar 19
Clinic Revenue$297.38K$176.40K$112.36K$105.85K$6.23K$37.51K---------
Product Revenue--$33.78K$56.75K$6.30K$2.79K$29.90K--------
License Revenue----$3.04M$178.57K$178.57K$178.57K-------
DomesticLicensingDistributionFeeMember--------$178.57K$178.57K$178.57K----
DomesticPhysiciansMember--------$18.00K$157.50K$67.50K----
Domestic Licensing Distribution Fee-----------$178.57K$178.57K$178.57K$178.57K
Domestic Physicians-----------$80.00K$125.00K$480.07K$10.86K

INVO Bioscience's latest quarterly revenue breakdown by geography, as of Mar 23: Clinic Revenue (100.00%).

INVO Bioscience Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
CLPSCLPS In$150.36M$71.77M
INVOINVO Bioscience$3.02M$1.58M
NLSPNLS Pharmaceutics--
LIXTLixte Biotechnology--
ENTXEntera Bio-$57.00K
ENVBEnveric Biosciences--

INVO Revenue FAQ


INVO Bioscience's yearly revenue for 2023 was $3.02M, representing an increase of 267.38% compared to 2022. The company's yearly revenue for 2022 was $822.2K, representing a decrease of -80.24% compared to 2021. INVO's yearly revenue for 2021 was $4.16M, representing an increase of 301.06% compared to 2020.

INVO Bioscience's quarterly revenue for Q1 2024 was $1.58M, a 14.08% increase from the previous quarter (Q4 2023), and a 352.92% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $1.38M, a 41.73% increase from the previous quarter (Q3 2023), and a 396.78% increase year-over-year (Q4 2022). INVO's quarterly revenue for Q3 2023 was $974.89K, a 208.61% increase from the previous quarter (Q2 2023), and a 314.28% increase year-over-year (Q3 2022).

INVO Bioscience's revenue growth rate for the last 3 years (2021-2023) was -27.39%, and for the last 5 years (2019-2023) was 104.06%.

INVO Bioscience's revenue streams in c 22 are Clinic Revenue

For the fiscal year ending Dec 22, the largest source of revenue of INVO Bioscience was Clinic Revenue. This segment made a revenue of $614.85K, representing 100.00% of the company's total revenue.